Kardigan, Inc.

NASDAQ:KARD

Biotechnology

Healthcare
$12.32 +3.50%

+$0.77 today

Market cap
$1.10B
Beta
0.00
52W Low $16.25High $24.00

Volume 0.55M

Average 5.84M

KARD Operating Cash Flow

Cash generated by the company's core business operations during the period.

No reported Operating Cash Flow figures are available to summarize.

Operating Cash Flow history

Currency unavailable · from the cash flow

No Operating Cash Flow data reported for this period type.

Operating Cash Flow vs competitors

How KARD compares with its peers on the latest reported figures

KARD Competitors
Operating Cash Flow for KARD and competitors
Company Period LTM YoY 3-year CAGR% of revenue
CYTKCytokinetics, IncorporatedLTM Jun 2026$555.45M USD+30.1%+19.4%782.8%
NAMSNewAmsterdam Pharma Company N.V.LTM Jun 2026$143.46M USD+15.6%—2014.6%
TNYATenaya Therapeutics, Inc.LTM Mar 2026$64.39M USD-24.2%-13.2%28616.0%
RNAAtrium Therapeutics, Inc.FY2025$41.13M USD——220.9%
IKTInhibikase Therapeutics, Inc.LTM Mar 2026$35.74M USD+84.4%+17.0%—
KARDKardigan, Inc.—— ———
Peer median (excluding KARD) —+22.8%+17.0%1398.7%

Competitors are the stored peer set for KARD. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Kardigan, Inc.

NASDAQ:KARD

Intrinsic Alpha fair value

Locked

Current Price

$12.32

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.